ZA988064B - Protease inhibitors - Google Patents
Protease inhibitorsInfo
- Publication number
- ZA988064B ZA988064B ZA988064A ZA988064A ZA988064B ZA 988064 B ZA988064 B ZA 988064B ZA 988064 A ZA988064 A ZA 988064A ZA 988064 A ZA988064 A ZA 988064A ZA 988064 B ZA988064 B ZA 988064B
- Authority
- ZA
- South Africa
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5752797P | 1997-09-04 | 1997-09-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA988064B true ZA988064B (en) | 1999-05-28 |
Family
ID=22011125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA988064A ZA988064B (en) | 1997-09-04 | 1998-09-03 | Protease inhibitors |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1015438A4 (en) |
JP (1) | JP2001514257A (en) |
AU (1) | AU9300298A (en) |
CA (1) | CA2302361A1 (en) |
CO (1) | CO4970736A1 (en) |
MA (1) | MA26540A1 (en) |
PE (1) | PE115699A1 (en) |
SA (1) | SA98190653A (en) |
WO (1) | WO1999011637A1 (en) |
ZA (1) | ZA988064B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
US6534498B1 (en) | 1999-11-10 | 2003-03-18 | Smithkline Beecham Corporation | Protease inhibitors |
JP2003513972A (en) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | Protease inhibitor |
WO2001034599A1 (en) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Protease inhibitors |
EA005893B1 (en) | 2000-03-21 | 2005-06-30 | Смитклайн Бичам Корпорейшн | Protease inhibitors |
WO2002083863A2 (en) | 2001-04-17 | 2002-10-24 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
WO2003062192A1 (en) | 2002-01-17 | 2003-07-31 | Smithkline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
KR100962972B1 (en) | 2002-07-26 | 2010-06-09 | 주식회사유한양행 | 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
DE102004008141A1 (en) | 2004-02-19 | 2005-09-01 | Abbott Gmbh & Co. Kg | Guanidine compounds and their use as binding partners for 5-HT5 receptors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59225172A (en) * | 1983-06-03 | 1984-12-18 | Yamanouchi Pharmaceut Co Ltd | Novel guanidinothiazole derivative and its preparation |
-
1998
- 1998-09-01 MA MA25238A patent/MA26540A1/en unknown
- 1998-09-03 ZA ZA988064A patent/ZA988064B/en unknown
- 1998-09-03 CO CO98050517A patent/CO4970736A1/en unknown
- 1998-09-03 EP EP98945850A patent/EP1015438A4/en not_active Withdrawn
- 1998-09-03 CA CA002302361A patent/CA2302361A1/en not_active Abandoned
- 1998-09-03 WO PCT/US1998/018289 patent/WO1999011637A1/en not_active Application Discontinuation
- 1998-09-03 AU AU93002/98A patent/AU9300298A/en not_active Abandoned
- 1998-09-03 JP JP2000508676A patent/JP2001514257A/en not_active Withdrawn
- 1998-09-04 PE PE1998000830A patent/PE115699A1/en not_active Application Discontinuation
- 1998-10-17 SA SA98190653A patent/SA98190653A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CO4970736A1 (en) | 2000-11-07 |
JP2001514257A (en) | 2001-09-11 |
WO1999011637A1 (en) | 1999-03-11 |
EP1015438A1 (en) | 2000-07-05 |
AU9300298A (en) | 1999-03-22 |
EP1015438A4 (en) | 2000-11-08 |
PE115699A1 (en) | 2000-01-13 |
MA26540A1 (en) | 2004-12-20 |
CA2302361A1 (en) | 1999-03-11 |
SA98190653A (en) | 2005-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL131661A0 (en) | Protease inhibitors | |
PL336589A1 (en) | Serinic protease inhibitors | |
PL349192A1 (en) | Protease inhibitors | |
ZA98376B (en) | Sulfamide-metalloprotease inhibitors | |
GB2321641B (en) | Sulfamide-metalloprotease inhibitors | |
PL328307A1 (en) | Serinic protease inhibitors | |
EP0744948A4 (en) | Protease inhibitors | |
IL132088A0 (en) | Protease inhibitors | |
ZA983841B (en) | Protease inhibitors | |
EP1093367A4 (en) | Protease inhibitors | |
IL132629A0 (en) | Protease inhibitors | |
ZA988479B (en) | Protease inhibitors | |
PL328875A1 (en) | Serinic protease inhibitors | |
PL328223A1 (en) | Aspartil protease inhibitors | |
EP1067894A4 (en) | Protease inhibitors | |
EP1079821A4 (en) | Protease inhibitors | |
ZA988064B (en) | Protease inhibitors | |
EP1140897A4 (en) | Protease inhibitors | |
EP1086083A4 (en) | Protease inhibitors | |
EP0975612A4 (en) | Protease inhibitors | |
ZA983097B (en) | Protease inhibitors | |
ZA977032B (en) | Protease inhibitors | |
GB9420277D0 (en) | Protease inhibitors | |
GB9725783D0 (en) | Inhibitors | |
GB9727371D0 (en) | Inhibitors |